Recce Pharmaceuticals - Supportive advancements on the pipeline
Recce Pharmaceuticals has announced several positive developments in recent weeks relating to its therapeutic programmes, particularly for lead...
220 Views
Recce Pharmaceuticals - Landmark commitment helps fund R&D costs
Recce recently reported that the Australian government has committed to providing up to A$55m in future cash rebates to reimburse upcoming R&D...
303 Views
Recce Pharmaceuticals - R327 continues to progress in clinical trials
Recce Pharmaceuticals raised A$11.0m (gross) in September and October. Most of the proceeds (A$6m) will be directed towards the company’s clinical...
255 Views
Recce Pharmaceuticals - R327 progressing in rapid infusion study
Recce recently reported the completion of its data review from its earlier long-infusion Phase I study of the intravenous (IV) RECCE 327 (R327)...
311 Views
Recce Pharmaceuticals - Gearing up for more R327 studies
Recent months have been eventful for Recce Pharmaceuticals, with the company presenting its Q323 operational update and announcing ethics approval...
163 Views